Ain Pharmaciez Inc (9627)

Currency in JPY
5,868.0
+29.0(+0.50%)
Delayed Data·

9627 Financial Summary

Key Ratios

P/E Ratio19.82
Price/Book1.29
Debt / Equity27.15%
Return on Equity6.67%
Dividend Yield1.37%
EBITDA30.88B
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2016
30/04
2017
30/04
2018
30/04
2019
30/04
2020
30/04
2021
30/04
2022
30/04
2023
30/04
2024
30/04
2025
30/04
* In Millions of JPY (except for per share items)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 264.31%
Dividend Yield
1.37%
Industry Median 1.55%
Annualised payout
80.00
Paid unevenly
5-Years Growth
+7.78%
Growth Streak

Analyst Ratings

2 Buy
2 Hold
1 Sell
Ratings:
5 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 6,560.0
(+11.79% Upside)

Earnings

Latest Release
Jun 05, 2025
EPS / Forecast
54.27 / 79.56
Revenue / Forecast
119.97B / 123.30B
EPS Revisions
Last 90 days

FAQ

What were Ain Pharmaciez Inc's earnings for the latest quarter?

The Ain Pharmaciez Inc EPS (TTM) is 264.31. Ain Pharmaciez Inc reported sales of 119,970.00, net income of 1,904.00, and EPS of 54.27 for the latest quarter.

What was Ain Pharmaciez Inc's net income for the latest quarter?

Ain Pharmaciez Inc's net income for the latest quarter was 1,904.00.

How did Ain Pharmaciez Inc's performance compare year-over-year in the latest quarter?

The company's revenue moved from 121,974.00 in the previous quarter to 119,970.00 in the latest quarter, and net income moved from 4,145.00 to 1,904.00 compared to the previous quarter.

What is Ain Pharmaciez Inc's net profit margin on a TTM basis?

Ain Pharmaciez Inc's trailing twelve months (TTM) net profit margin is 2.03%.

How does Ain Pharmaciez Inc's debt to equity ratio compare to industry standards?

Ain Pharmaciez Inc's total debt-to-equity ratio is 27.15%.

What is Ain Pharmaciez Inc's return on investment on a TTM basis?

Ain Pharmaciez Inc's trailing twelve months (TTM) return on investment (ROI) is 6.67%.

What were Ain Pharmaciez Inc's total assets and liabilities in the latest quarter?

As of the latest quarter, Ain Pharmaciez Inc reported total assets of 311,921.00 million and total liabilities of 132,045.00 million.

How has Ain Pharmaciez Inc's total revenue grown this year?

Ain Pharmaciez Inc's total revenue was 121,974.00 in the previous quarter and 119,970.00 in the latest quarter.

What is Ain Pharmaciez Inc's gross margin on a TTM basis?

Ain Pharmaciez Inc's trailing twelve months (TTM) gross margin is 16.29%.

What was Ain Pharmaciez Inc's revenue per share for the latest quarter?

Ain Pharmaciez Inc's revenue per share for the latest quarter was 8,181.57.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.